YR, P., M, B. . and CK , S. . (2021) “GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF 25 MG FULL TABLET VERSUS 12.5 MG HALF TABLET EMPAGLIFLOZIN IN THE TREATMENT OF TYPE 2 DIABETES (T2D): A SINGLE CENTRE EXPERIENCE”, Journal of the ASEAN Federation of Endocrine Societies, 36, p. 44. doi: 10.15605/jafes.036.S60.